Short description
Neurolytixs is a biotechnology company that develops health care technology to aid biomarker discovery for the diagnosis of concussions.
Description
Neurolytixs is a health care technology intended to aid biomarker discovery for the diagnosis of concussions. They have leveraged artificial intelligence to diagnose concussions with blood biomarker tests. They utilize machine learning, artificial intelligence, and blood tests, enabling the sports industry to better diagnose concussions on site.
Last funding
Noaccessforu
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Toronto, Ontario, Canada, North America
Founded on
January 1, 2020
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$34056 - 789030
Sign in for full access
Investors
Noaccessforu
Sign in for full access
Founders
Adrian Uthayagumaran, Douglas Fraser, Peter George